医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Taro to Announce Second Quarter Results on November 5, 2018

2018年10月30日 AM04:15
このエントリーをはてなブックマークに追加


 

HAWTHORNE, N.Y.

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2018, on Monday, November 5, 2018.

The Company will conduct an earnings call at 8:00 am EST on Tuesday, November 6, 2018, where senior management will discuss the Company’s performance and answer questions from participants.

The earnings release will be accessible on Taro’s website at www.taro.com.

Earnings Call (8:00 am EST on Tuesday, November 6, 2018)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

 

Summary of events

Event     Date and time     Telephone number/ website
Earnings release     November 5, 2018 (AMC)    

www.taro.com

Earnings conference call     8:00 am EST

November 6, 2018

   

Participant Toll-Free Dial-In Number: +1 (844) 421-0601

Participant International Dial-In Number: +1 (716) 247-5800

Conference ID: 2871389

 

Via audio webcast, details of which will be made available on www.taro.com

Replay of conference call     November 6, 2018 to

November 18, 2018

   

+ 1 (855) 859-2056 or +1 (404) 537-3406

Conference ID: 2871389

 

Via audio webcast playback, details of which will be made available on www.taro.com

       

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181029005695/en/

CONTACT

Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer
VP,
CFO
(914) 345-9001
Mariano.Balaguer@taro.com
or
William
J. Coote

AVP, Business Finance, Treasurer and Investor Relations
(914)
345-9001
William.Coote@taro.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • サラダックス・バイオメディカル、サルバトーレ・J・サラモネ博士が権威ある C.E. Pippenger博士賞を受賞したと発表
  • Japan’s MHLW Approves PADCEV® (enfortumab vedotin) for Advanced Urothelial Cancer
  • VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan
  • TAE Life Sciences Announces Installation of First Accelerator-based Neutron Beam System for Biologically Targeted Radiation Therapy at Xiamen Humanity Hospital in China
  • New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates